ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,327Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 1171

$465K Total Retail Price of All Prescriptions

Rank: 250 out of 1171

390 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 6,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 559 387 1 2
SIMVASTATIN 377 266 2 1
FUROSEMIDE 357 260 3 6
WARFARIN SODIUM 349 254 4 12
OMEPRAZOLE 272 132 5 5
TRAMADOL HCL 261 170 6 18
HYDROCHLOROTHIAZIDE 197 122 7 9
LISINOPRIL 192 146 8 3
METFORMIN HCL 180 119 9 7
CARVEDILOL 166 128 10 20
GABAPENTIN 159 83 11 16
DONEPEZIL HCL 140 140 12 24
LEVOTHYROXINE SODIUM 133 108 13 4
CLONIDINE HCL 128 107 14 45
DIOVAN HCT 121 111 15 65
HYDROCODONE-ACETAMINOPHEN 120 60 S3 16 8
ATORVASTATIN CALCIUM 118 86 17 10
METOPROLOL TARTRATE 115 99 18 11
AMITRIPTYLINE HCL 103 78 R 19 74
ATENOLOL 99 54 20 15
CLOPIDOGREL 93 52 21 35
LOSARTAN POTASSIUM 92 70 22 14
NAMENDA 90 90 23 42
ISOSORBIDE MONONITRATE ER 87 71 24 44
PROAIR HFA 85 40 25 49
GLIPIZIDE XL 84 76 26 124
LOSARTAN-HYDROCHLOROTHIAZIDE 82 72 27 40
PHENYTOIN SODIUM EXTENDED 81 35 28 137
DIOVAN 81 34 28 32
CITALOPRAM HBR 76 71 30 22
KLOR-CON M20 73 57 31 41
JANUVIA 70 42 32 66
METOPROLOL SUCCINATE 64 35 33 17
DOXAZOSIN MESYLATE 63 54 34 82
POTASSIUM CHLORIDE 62 51 35 19
CELEBREX 58 49 36 100
CYCLOBENZAPRINE HCL 56 25 R 37 67
GLIPIZIDE ER 54 38 38 86
MEGESTROL ACETATE 53 44 R 39 185
AMLODIPINE BESYLATE-BENAZEPRIL 53 30 39 70
TRAZODONE HCL 53 36 39 37
DILTIAZEM 24HR ER 53 51 39 112
METFORMIN HCL ER 52 31 43 52
LANTUS 52 36 43 46
HYDRALAZINE HCL 52 41 43 60
IBUPROFEN 51 0 46 80
PLAVIX 51 35 46 55
NAPROXEN 50 23 48 95
COLCRYS 50 39 48 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.